This compound is a PEGylated pharmaceutical intermediate featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and a terminal carboxylic acid. It is primarily used in the synthesis of PEGylated compounds for research and pharmaceutical manufacturing.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 139338-72-0
23-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,6,9,12,15,18,21-heptaoxatricosanoic acid
PEGylated Fmoc-protected amino acid reagent
2-{2-[2-({[(9H-FLUOREN-9-YL)METHOXY]CARBONYL}AMINO)ETHOXY]ETHOXY}ACETIC ACID
Fmoc-protected PEG linker for peptide synthesis
2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid
Research compound for conjugation
Fmoc-AEEA-AEEA
peptide synthesis intermediate
5-Bromo-2-(trifluoromethoxy)benzyl chloride
Pharmaceutical intermediate
5-Acetyl-6-hydroxypicolinaldehyde
pharmaceutical intermediate
2-[(3R,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]ethanol
Pharmaceutical intermediate
(2-((3R,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)cyclohexylidene)ethyl)diphenylphosphine oxide
phosphine oxide intermediate for synthesis
2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]acetic acid
XNOJSAOJCBOZTA-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCC(=O)O